Found 11 matching trials
Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients PHASE2 5 month study comparing SOM230 s.c. and Sandostatin s.c. in acromegalic pat...
Show More Location
Cedars Sinai Medical Center
Learn More & Join Trial
Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size PHASE2 This is a monocenter, single-arm, open label phase II trial evaluating the ...
Show More Location
Klinik und Poliklinik für Neurologie der Universität Regensburg
Learn More & Join Trial
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET PHASE3 The purpose of the current study is to evaluate the efficacy and safety of ...
Show More Location
Mayo Clinic Arizona
Learn More & Join Trial
Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly PHASE3 This study will evaluate the efficacy and safety of pasireotide LAR 40 and ...
Show More Location
University of Michigan
Learn More & Join Trial
Treatment Plan for an Individual Patient With Pasireotide for Hyperinsulinemic Hypoglycemia PHASE1 Somatostatin analogues are a last resort for medical intervention in hyperi...
Show More Location
University of Colorado Denver
Learn More & Join Trial
Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease PHASE3 The purpose of this randomized, multicenter, Phase III study was to compare...
Show More Location
Scottsdale Healthcare/TGen Clinical Research Service TGen Clinical Research Service
Learn More & Join Trial
Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET PHASE3 The aim of NETTER-2 was to determine if Lutathera in combination with long-...
Show More Status
Active Not Recruiting
Location
Yale Cancer Center
Learn More & Join Trial
Pasireotide LAR and Pegvisomant Study in Acromegaly PHASE4 The objective of this study is to assess the efficacy of Pasireotide Long A...
Show More Location
Erasmus Medical Center
Learn More & Join Trial
Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors PHASE2 Study evaluating SOM230 in patients with metastatic carcinoid tumors...
Location
Cedars-Sinai Medical Center
Learn More & Join Trial
An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly PHASE2 Acromegaly is a rare, serious condition characterized by chronic hypersecre...
Show More Location
Cedars Sinai Medical Center Dept. of Pituitary Ctr.
Learn More & Join Trial